Journal of ethnopharmacology · 2025
An in vitro, in vivo and in silico assessment of fat absorption inhibition by a gymnemic acid rich extract of Gymnema sylvestre leaves.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Santos Thalita Faleiros Demito, Souza Gustavo H, Silva Beatriz Paes, Viana Neto Gabriel Arcanjo, Silva Milena Thais Francisco, Souza Cristina Giatti Marques de, Bracht Livia, Comar Jurandir F, Peralta Rosane M, Bracht Adelar, Sá-Nakanishi Anacharis B
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Hyperlipidemia is a metabolic disturbance linked to the metabolic syndrome, obesity, and diabetes. Gymnema sylvestre is a plant used in Ayurvedic folk medicine to control hyperglycemia and hyperlipidemia. These effects have received support by a fair number of investigations.
AIM OF THE STUDY: The objective of this study was to elucidate the mechanisms underlying the anti-hyperlipidemic effects of a commercial extract derived from Gymnema sylvestre leaves, standardized to 75 % gymnemic acids ("Gymnema sylvestre 75").
MATERIALS AND METHODS: In vivo, in vitro and in silico experiments were done, encompassing several aspects of fat absorption.
RESULTS: Pancreatic lipase assays revealed that the extract inhibited hydrolysis of triglycerides. This effect is of the non-competitive type and incomplete (parabolic kinetics). Maximal inhibition at saturating substrate concentrations reached 65 %. Triglyceride tolerance tests in mice indicated inhibition of fat absorption with an ID50 of 41.4 mg/kg. This dose is much smaller than expected from the in vitro lipase inhibition (IC50 = 484.6 μg/mL) and suggests a more complex mechanism than the simple inhibition of the pancreatic lipase. Notably, the observed inhibition of free oleate absorption by the extract implies that inhibition of the intestinal fatty acyl transporter may represent an additional mode of action. In silico studies revealed strong binding of gymnanegin and gymnemoside B to the pancreatic lipase.
CONCLUSION: The inhibition of the pancreatic lipase and fatty acyl transport by the G. sylvestre extract likely play a pivotal role in reducing hyperlipidemia and promoting effective body weight control in animals.
AIM OF THE STUDY: The objective of this study was to elucidate the mechanisms underlying the anti-hyperlipidemic effects of a commercial extract derived from Gymnema sylvestre leaves, standardized to 75 % gymnemic acids ("Gymnema sylvestre 75").
MATERIALS AND METHODS: In vivo, in vitro and in silico experiments were done, encompassing several aspects of fat absorption.
RESULTS: Pancreatic lipase assays revealed that the extract inhibited hydrolysis of triglycerides. This effect is of the non-competitive type and incomplete (parabolic kinetics). Maximal inhibition at saturating substrate concentrations reached 65 %. Triglyceride tolerance tests in mice indicated inhibition of fat absorption with an ID50 of 41.4 mg/kg. This dose is much smaller than expected from the in vitro lipase inhibition (IC50 = 484.6 μg/mL) and suggests a more complex mechanism than the simple inhibition of the pancreatic lipase. Notably, the observed inhibition of free oleate absorption by the extract implies that inhibition of the intestinal fatty acyl transporter may represent an additional mode of action. In silico studies revealed strong binding of gymnanegin and gymnemoside B to the pancreatic lipase.
CONCLUSION: The inhibition of the pancreatic lipase and fatty acyl transport by the G. sylvestre extract likely play a pivotal role in reducing hyperlipidemia and promoting effective body weight control in animals.